报价延迟最少15分钟:2025/08/25 15:32 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.695 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-4.21/--
|
|
企业价值
156.05M
|
| 资产负债 |
|
每股账面净值
-1.93
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
53.49M
|
|
每股收益
3.20
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/25 15:32 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia. |
